We have virtually no large-scale human clinical trials to validate safety
In tendon repair models where avascular healing is a well-recognized limitation BPC-157 administration in Wistar rat Achilles tendon transection experiments produced statistically significant increases in vessel density within the repair zone at 14 days post-transection compared to saline controls, accompanied by increased tensile strength measurements consistent with more mature, vascularized repair tissue
Plus the cardiac mortality was twice less in patients treated with peptide than those in the control group.[11]
One unit on a 1 ml (100-unit) insulin syringe equals 0.5 mg of Epithalon
Rau c: t chung, sp l xanh, sp l trng, mi ty, su ho, bp ci, ci xon, ci tha, u tuyt